{"entity":{"type":"insider","cik":"0001616640","url":"/insider/0001616640","json_url":"/insider/0001616640.json","name":"AGARWAL SUNIL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":14,"first":"2015-08-21","last":"2021-09-17","span_basis":"filed_date"},"name_variants":[{"name":"AGARWAL SUNIL","source":"filing","n_filings":14,"first_seen":"2015-08-21","last_seen":"2021-09-17"}],"transactions":[{"id":4818275,"accession":"0001562180-21-005999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-005999","line_url":"/filing/0001562180-21-005999#line-2","is_derivative":false,"issuer_cik":"0001616640","issuer_name":"Sana Biotechnology, Inc.","issuer_ticker":"SANA","issuer_name_source":null,"issuer_url":"/issuer/0001616640","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (EVP, Head of Development & CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Head of Development & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of Development & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1627.0,"shares_display":"1,627","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":42302.0,"total_display":"42,302.00","total_whole":"42,302","shares_owned_after":1550000.0,"shares_owned_after_display":"1,550,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-17","scope":"insider"},{"id":4818270,"accession":"0001562180-21-005999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-005999","line_url":"/filing/0001562180-21-005999#line-1","is_derivative":false,"issuer_cik":"0001616640","issuer_name":"Sana Biotechnology, Inc.","issuer_ticker":"SANA","issuer_name_source":null,"issuer_url":"/issuer/0001616640","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (EVP, Head of Development & CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Head of Development & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of Development & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58373.0,"shares_display":"58,373","price_per_share":26.0695,"price_display":"26.07","price_state":"stated","total_value":1521754.9235,"total_display":"1,521,754.92","total_whole":"1,521,755","shares_owned_after":1551627.0,"shares_owned_after_display":"1,551,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":5353450,"accession":"0001209191-17-056034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-056034","line_url":"/filing/0001209191-17-056034#line-1","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (President of R & D)","role_mark":"O","role_mark_label":"Officer (President of R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7285.0,"shares_display":"7,285","price_per_share":44.7616,"price_display":"44.76","price_state":"stated","total_value":326088.256,"total_display":"326,088.26","total_whole":"326,088","shares_owned_after":84549.0,"shares_owned_after_display":"84,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":2920176,"accession":"0001562180-16-002830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-002830","line_url":"/filing/0001562180-16-002830#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":649.0,"shares_display":"649","price_per_share":52.68,"price_display":"52.68","price_state":"stated","total_value":34189.32,"total_display":"34,189.32","total_whole":"34,189","shares_owned_after":9528.0,"shares_owned_after_display":"9,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-21","filed_date":"2016-07-21","scope":"insider"},{"id":2532884,"accession":"0001562180-16-002672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-002672","line_url":"/filing/0001562180-16-002672#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":54.16,"price_display":"54.16","price_state":"stated","total_value":35204.0,"total_display":"35,204.00","total_whole":"35,204","shares_owned_after":10569.0,"shares_owned_after_display":"10,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-20","filed_date":"2016-06-21","scope":"insider"},{"id":2224641,"accession":"0001562180-16-002430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002430","line_url":"/filing/0001562180-16-002430#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":66.0,"price_display":"66.00","price_state":"stated","total_value":42900.0,"total_display":"42,900.00","total_whole":"42,900","shares_owned_after":7111.0,"shares_owned_after_display":"7,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-26","scope":"insider"},{"id":2752600,"accession":"0001562180-16-002153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-002153","line_url":"/filing/0001562180-16-002153#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":649.0,"shares_display":"649","price_per_share":70.53,"price_display":"70.53","price_state":"stated","total_value":45773.97,"total_display":"45,773.97","total_whole":"45,774","shares_owned_after":8567.0,"shares_owned_after_display":"8,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-21","scope":"insider"},{"id":2876768,"accession":"0001562180-16-002028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002028","line_url":"/filing/0001562180-16-002028#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":61.45,"price_display":"61.45","price_state":"stated","total_value":39942.5,"total_display":"39,942.50","total_whole":"39,943","shares_owned_after":9608.0,"shares_owned_after_display":"9,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-22","filed_date":"2016-03-24","scope":"insider"},{"id":3053203,"accession":"0001562180-16-001766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-001766","line_url":"/filing/0001562180-16-001766#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":658.0,"shares_display":"658","price_per_share":63.48,"price_display":"63.48","price_state":"stated","total_value":41769.84,"total_display":"41,769.84","total_whole":"41,770","shares_owned_after":10650.0,"shares_owned_after_display":"10,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-02-23","scope":"insider"},{"id":2856401,"accession":"0001562180-16-001371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-001371","line_url":"/filing/0001562180-16-001371#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":585.0,"shares_display":"585","price_per_share":72.83,"price_display":"72.83","price_state":"stated","total_value":42605.55,"total_display":"42,605.55","total_whole":"42,606","shares_owned_after":12190.0,"shares_owned_after_display":"12,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-20","filed_date":"2016-01-21","scope":"insider"},{"id":8386526,"accession":"0001562180-15-001119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-001119","line_url":"/filing/0001562180-15-001119#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":114.81,"price_display":"114.81","price_state":"stated","total_value":57175.38,"total_display":"57,175.38","total_whole":"57,175","shares_owned_after":13231.0,"shares_owned_after_display":"13,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2015-12-24","scope":"insider"},{"id":8928052,"accession":"0001562180-15-001001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-001001","line_url":"/filing/0001562180-15-001001#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":95.88,"price_display":"95.88","price_state":"stated","total_value":47748.24,"total_display":"47,748.24","total_whole":"47,748","shares_owned_after":13775.0,"shares_owned_after_display":"13,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-24","scope":"insider"},{"id":8910299,"accession":"0001562180-15-000873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-15-000873","line_url":"/filing/0001562180-15-000873#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":649.0,"shares_display":"649","price_per_share":85.51,"price_display":"85.51","price_state":"stated","total_value":55495.99,"total_display":"55,495.99","total_whole":"55,496","shares_owned_after":14817.0,"shares_owned_after_display":"14,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-20","filed_date":"2015-10-21","scope":"insider"},{"id":8587822,"accession":"0001562180-15-000791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000791","line_url":"/filing/0001562180-15-000791#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":109.51,"price_display":"109.51","price_state":"stated","total_value":54535.98,"total_display":"54,535.98","total_whole":"54,536","shares_owned_after":15858.0,"shares_owned_after_display":"15,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-22","filed_date":"2015-09-24","scope":"insider"},{"id":8872659,"accession":"0001562180-15-000703","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001562180-15-000703","line_url":"/filing/0001562180-15-000703","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001616640","owner_name":"AGARWAL SUNIL","owner_display_name":"AGARWAL SUNIL","owner_url":"/insider/0001616640","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17020.0,"shares_display":"17,020","price_per_share":111.1757862279671,"price_display":"111.18","price_state":"stated","total_value":1892211.8816,"total_display":"1,892,211.88","total_whole":"1,892,212","shares_owned_after":19830.0,"shares_owned_after_display":"19,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-21","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770121","name":"Sana Biotechnology, Inc.","url":"/issuer/0001770121","role":"Officer (EVP, Head of Development & CMO)","n_filings":1,"first_seen":"2021-09-17","last_seen":"2021-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001594864","name":"Juno Therapeutics, Inc.","url":"/issuer/0001594864","role":"Officer (President of R & D)","n_filings":1,"first_seen":"2017-10-04","last_seen":"2017-10-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Officer (Chief Medical Officer)","n_filings":12,"first_seen":"2015-08-21","last_seen":"2016-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001616640","retrieved_at":"2026-08-24T18:21:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}